Connect with us

Cannabis News

World Health Organization Won’t Ease Coca Leaf Ban, Even As Review Found Prohibition Is More Dangerous Than The Plant

Published

1 month ago

on

“It is unacceptable for humanity to demonize a sacred medicinal plant. It was a political decision rather than a scientific one.”

By Mattha Busby, Filter

The The World Health Organization had a historic opportunity to ease the strict global ban on the coca leaf-ban, campaigners said, “racist and colonial” the roots. But the agency has decided not to.

WHO expert review he determined in September how millions of people in the Andes consume the coca leaf daily as part of a long-standing cultural practice without significant negative effects, and conversely that coca control strategies are associated with significant public health harm.

And yet, on December 2nd, the WHO’s Expert Committee on Drug Dependence (ECDD) recommended that the plant be kept in Annex I of the United Nations drug treaties—the most restrictive category of control—because coca leaves can be converted relatively easily into cocaine.

“The simplicity of extracting cocaine from cocaine and its high yield and profitability are well known,” ECDD wrote. “The Commission has also examined evidence of significant increases in the cultivation of cocaine and the production of cocaine-related substances in the context of significant and growing public health concerns about the use of cocaine. In this context, the Commission believes that the reduction or elimination of international controls on the coca leaf may pose a particularly serious risk to public health.”

The commission noted a 34 percent year-on-year increase in cocaine production in 2023, with some countries experiencing historically high levels. But supporters of reform emphasize that coke is not cocaine. They point out that the WHO review supports the plant’s medical potential and the lack of evidence of problematic coca leaf use anywhere in the world — two key criteria a drug must meet to be placed on a less restrictive schedule.

“It is unacceptable for humanity to demonize a sacred medicinal plant”, Jaison Perez Villafaña, guardian of wisdom or mother From the Arhuaco community in Colombia, he said The filter. “It was a political decision rather than a scientific one. Coca leaf (help) is not to blame for the fact that humans with economic interests turned it into cocaine”.

The ECDD said it recognized that “the coca leaf has important cultural and therapeutic value to indigenous peoples and other communities and that there are exceptions to the traditional use of the coca leaf in certain national settings.” A coalition of indigenous coca leaf producers and consumers he wrote The WHO in October asked the UN body to “clearly distinguish” between traditional coca use and cocaine-related issues.

Steve Rolles, senior policy analyst at the Transform Drug Policy Foundation, called the WHO’s suggestion that keeping coca on Schedule 1 would limit cocaine production “ridiculous”, saying the decision exposed the “moral and scientific failure” of drug control worldwide.

“While we might expect them to emerge from political institutions embedded in drug war narratives, there was a sense that the more objective, scientific and nominally independent corners of the UN would maintain a level of pragmatism and principle, even if their recommendations were later rejected by UN political entities.” he wrote It’s LinkedIn.

“The dangers of cocaine powder or smoked crack cocaine, creations of the global North, which is also by far the largest market for both, depend on the traditional use of coca, chewed or in tea, which only occurs in the South,” added Rolles. “It is the global South where the burden of the failed war on cocaine and the criminalization of entire cultures is felt most acutely.”

In 2020, following a WHO recommendation, the United Nations Commission on Narcotic Drugs voted to ease international controls on cannabis, recognizing its medical value after decades of “referral madness”. For reform advocates, the decision represented a slow and delayed shift to evidence-based programming. That is why there was hope that the UN system could also separate the coca leaf — which contains less than 1 percent of the alkaloid cocaine — from the refined powder that feeds global demand.

However, coca will continue to be treated as if it has the same risk profile as cocaine, after a WHO review confirmed that coca chewing has not caused any documented deaths, is not associated with high addiction or “abuse” potential, and has possible therapeutic applications, from anti-inflammatory effects to modest improvements in post-meal glucose.

“The WHO decision is deeply disappointing and disturbing,” Ann Fordham, executive director of the International Council on Drug Policy, said in a press release. “This was no ordinary study, it was a critical test of the UN drug control system. The Commission has demonstrated that it cannot objectively assess the evidence or consider the human rights implications of prohibition. Instead, it has chosen to reinforce the racist and colonial foundations of international drug control. This decision makes it clear that the system is broken and resistant to meaningful reform.”

Experts have long argued that the logic behind the coca ban is selective and ignores existing treaty precedent. Plants such as ephedra used to manufacture methamphetamine, psilocybin-containing mushrooms, and cacti that produce mescaline remain unscheduled at the plant level, although they are used to produce controlled substances.

While open persecution of coca chewers has eased in the Andes, the ban still shapes daily life in parts of the region, from farmers losing crops to stopping aerial fumigation campaigns, eradication forces and communities caught between the networks that dominate the cocaine trade. In a September study, an independent group of experts hired by the WHO said that studies that showed exposure to harmful glyphosate-based pesticides such as Roundup, a probable carcinogen, by aerial spraying of coca crops by authorities “increased the number of abortions and increased the number of medical consultations related to dermatological and respiratory diseases in communities”.

The review added that another study showed that forced coca eradication encouraged coca growers to increase production through the use of toxic agrochemicals “on more or subsequent coca plots, increasing exposure to these chemicals.”

Villafaña and other indigenous leaders have warned that these pressures are cultural violence. Coca is central to Andean communities’ spiritual practice, conflict resolution, work, ceremony, and community health; however, using it outside of the narrow “traditional” exemptions puts people at risk of criminal penalties.

“It would be useful for us as a culture,” said Villafaña, “if the world recognized it as a sacred plant and did not demonize it.” But, he added, the decision would not otherwise affect his community, as its members will continue to chew coca as they have always done.

This the article Originally published by the author the filteran online magazine that deals with drug use, drug policy and human rights from a harm reduction perspective. Keep the filter on Bluesky, X or Facebookand sign up for their newsletter.

Marijuana Moment is made possible with the help of readers. If you rely on our pro-cannabis journalism to stay informed, consider a monthly Patreon pledge.

Related Topics:
Continue Reading

Cannabis News

Technical advances in cannabis curing focus on water activity and terpene stability

Published

7 hours ago

on

January 18, 2026

By

Curing is one of those phases of cannabis production that almost everyone agrees is important, but that importance hardly translates into cannabis facilities. It’s understandable that growers want to maximize their canopy space first and foremost. After all, more flowers, more income. However, the irony is that by the time a plant reaches the curing room, most of the money has already been spent. The genetics are locked in, the lights have done their job, the rooms have been marked, the harvest has been carefully handled. And yet, quality is often validated or left behind.

Simon Knobel of Calyx Containers has spent an amazing amount of time thinking about this disintegration. The company started about 9 years ago, when Simon and his co-founder Alex were still in school and adult cannabis was becoming legal in Massachusetts. “Back then, cannabis packaging meant pill bottles, borrowed wholesale from the pharmaceutical world and reused without much thought,” explains Simon. “Our initial instinct wasn’t to do something revolutionary. It was just to build something that made sense for cannabis.”

As the company developed a range of packaging formats, the focus was on quality at the point of sale. “Scent retention, ease of use, shelf life, that was the pace of our design process. What took longer to fully register was that the degradation didn’t just happen after packaging. In many cases, it was already baked in during curing.”

Simon and Calyx did extensive market research to understand what was happening with quality degradation. “It’s good to talk not only with operators, but with consumers.” A story stuck. Simon recalls interviewing a client who was on a ski trip with his family and trying to hide the fact that he had cannabis with him. This awkwardness of smell, discretion and manipulation became a design problem. The sliding cover, integrated gasket, meant the elimination of the twisting motion that gave some users a literal pain in the wrist. But it also opened up a deeper line of research.

As Calyx began to talk more seriously with growers, a recurring question came up. Where exactly does quality start to slip? To answer this, the company partnered with the Cannabis Research Coalition and worked with Dr. Allison Justice on research based on the cure. “What we found was that it wasn’t particularly comfortable for anyone relying on legacy methods,” says Simon. “One of the biggest drivers of terpene preservation was the stability of water activity. When water activity drops below 0.55 aW, the stomata begin to collapse, then shrink, then break. At that point, the mono-terpenes escape.”

These mono-terpenes are responsible for most of the aromas associated with quality cannabis. “They are also volatile in nature. Once they’re gone, they’re gone,” highlighted Simon.

© Calyx Vessels

Basic methods and alternatives
Traditional healing methods are based on burping. Opening containers, exchanging air, manually regulating humidity. “This methodology works, but it also introduces oxygen. In addition, the plant material is also subject to mechanical stress. Both oxygen and mechanical stress accelerate degradation, thus hampering quality.”

Calyx Cure was designed as an alternative to that ritual. “Instead of active intervention, Calyx Cure uses a passive atmospheric film with selective permeation properties. The layers are designed to allow specific gases to move through the material while others are restricted. Biological curing processes continue, but without opening the container, without introducing excess oxygen and without handling the flower.”

In controlled studies, Calyx saw a 33% improvement in monoterpene profile preservation compared to traditional approaches such as turkey pouches. “Practically speaking, that first hit of aroma you get when you open a jar, driven largely by monoterpenes, is intact.”

Complicating the picture is that curing is not reversible. There is a persistent belief that if cannabis dries out too much, there are no moisture packs or other interventions that can bring it back. “Excessive drying slows down the enzymatic reactions, alters the aging process and permanently changes the composition of the terpenes. Once the quality is lost at that stage, the bottle cannot revive it,” he said.

© Calyx Vessels

Curing and speed to market
Therefore, post-harvest processes cannot be the last element of cannabis facility design. “Sometimes speed or short-term cost savings drive the decision. Cure less, move product faster and assume the container will handle the rest.” Market dynamics don’t help either. When a new market opens and the shelves are empty, speed is rewarded and cutting corners can be the difference between hitting dispensaries later.

Calyx approaches it as a manufacturing and engineering problem rather than a branding exercise. Unlike much of the packaging industry, which operates largely as a middleman, Calyx operates its own factory in Utah. “That vertical integration allows us to iterate quickly. New designs can be prototyped in 1 or 2 weeks.”

This can be a huge plus, as quality control is a hot topic in the wider world of agriculture, not just cannabis. The industry often talks about wanting nutraceutical or food standards. These industries have already solved the complexity of the supply chain. They know how to produce in one region and deliver consistently to another. Cannabis, especially if it wants to move globally, will need similar discipline.”

And as with food packaging, sustainability is part of that equation in cannabis. Calyx has extensively studied compostable and hemp-based structures. “Compostable materials struggle with terpene conservation and water activity control. If the package breathes too much, the plant pays the price.”

Instead, Calyx’s approach to sustainability is based on reducing the use of materials at the manufacturing level. “The cover molded joint is a good example,” explains Simon. “Traditional seals require cutting circular inserts from large sheets, creating huge waste. We’ve designed molds where a small amount of polymer forms the cover and joint in one plane, creating almost zero waste and a fully recyclable component.”

Healing, it seems, is not passive waiting. “It’s an active and fragile process,” says Simon. “And like most fragile things in cannabis, it benefits from being engineered rather than inherited.”

For more information:
Calyx vessels
1991 W Parkway Blvd. West Valley City, UT, 84119-2026
724-303-7481
(email protected)
calyxcontainers.com

Continue Reading

Cannabis News

Michigan Lawmakers Weigh Bill To Create Statewide Cannabis Reference Lab To Standardize Testing

Published

7 hours ago

on

January 18, 2026

By

The facility “will allow us to inspect test results from private laboratories.”

By Katherine Dailey, Michigan Advance

Seeking to ensure stricter safety controls in Michigan’s cannabis industry, Representative Mike Mueller (R-Linden) introduced a bill to the Michigan House Rules Committee on Thursday that would establish a statewide cannabis reference laboratory to standardize testing facilities across the state.

The legislation, House Bill 4501, would establish a lab that was first funded in fiscal year 2024 appropriations and has been in the process of opening ever since.

Derek Sova, policy and legislative assistant for the Michigan Cannabis Regulatory Agency, explained to the committee that this bill was essential to ensure that laboratories had explicit authority to possess marijuana, given that it is still a federally illegal substance.

Currently, there are 17 privately owned and state-licensed cannabis testing facilities or laboratories in Michigan, Sova explained.

But some manufacturers will engage in what they call “lab shopping,” where multiple labs test their products until they get the results they want.

This laboratory, he said, “will allow us to inspect the results of private laboratory tests.”

“We are not looking to take responsibility for the test,” Sova continued. “Our goal is to make sure that the labs that do the testing themselves, that the labs get the correct test results that have to do with the testing.”

He added that the laboratory will also provide the opportunity to carry out research in-house, as opposed to asking a private laboratory to conduct state examinations.

“What this would do is to have a central state-regulated lab that would be able to take samples from every lab that tests marijuana to make sure they’re not getting bad samples or that the bigger producers are manipulating some of the findings to make sure they’re not pushing things that could go wrong with marijuana,” Mueller said.

Representatives from the Michigan Cannabis Industry Association and the state Office of Licensing and Regulatory Affairs also expressed support. invoice.

This story was first published by the Michigan Advance.

Marijuana Moment is made possible with the help of readers. If you rely on our pro-cannabis journalism to stay informed, consider a monthly Patreon pledge.

Continue Reading

Cannabis News

Vivent Biosignals & Green Laniel join forces to bring plant-driven agriculture to the US

Published

1 day ago

on

January 17, 2026

By











Vivent Biosignals and Green Laniel Consulting have announced a partnership to accelerate plant-driven irrigation and irrigation in key U.S. agricultural markets. Green Laniel Consulting is a US-focused provider of agronomic solutions led by Mauricio Manotas.

By combining Vivent’s ability to decode plant biosignals in real-time using plant biosensors, machine learning and AI with Green Laniel’s deep experience in agronomy, grower operations and US market access, the partnership allows growers to make decisions based on what really matters: how the plant itself is responding.

© Vivent Biosignals

The partnership will cover a variety of crops and production systems, initially plant-driven irrigation and greenhouses for perennial crops, including potatoes, directly guided by plant feedback.

“By combining Vivint’s plant-level intelligence with Green Laniel’s strong presence and agronomic leadership in the US, we are enabling a new generation of plant-driven farming systems. This partnership helps growers improve yields and quality while significantly increasing resource efficiency and sustainability.” says Mauricio Manotas, Green Laniel Consulting.

For more information:
Vivent Biosignals
Tel.: +41 79 5114627
Email: (email protected)
https://vivent-biosignals.com/



Publication date:













Continue Reading
Advertisement

Trending

Copyright © 2021 The Art of MaryJane Media